• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immune Netw . SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues

tetano

Editor, Senior Moderator
Immune Netw


. 2021 Dec 23;21(6):e38.
doi: 10.4110/in.2021.21.e38. eCollection 2021 Dec.
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues


Sinae Kim[SUP] 1 2 [/SUP], Tam T Nguyen[SUP] 1 2 [/SUP], Afeisha S Taitt[SUP] 1 [/SUP], Hyunjhung Jhun[SUP] 3 [/SUP], Ho-Young Park[SUP] 4 [/SUP], Sung-Han Kim[SUP] 5 [/SUP], Yong-Gil Kim[SUP] 6 [/SUP], Eun Young Song[SUP] 7 [/SUP], Youngmin Lee[SUP] 8 [/SUP], Hokee Yum[SUP] 9 [/SUP], Kyeong-Cheol Shin[SUP] 10 [/SUP], Yang Kyu Choi[SUP] 2 [/SUP], Chang-Seon Song[SUP] 2 [/SUP], Su Cheong Yeom[SUP] 11 [/SUP], Byoungguk Kim[SUP] 12 [/SUP], Mihai Netea[SUP] 13 [/SUP], Soohyun Kim[SUP] 1 2 [/SUP]



Affiliations

Abstract

Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (B.1.1.529) Omicron variant originated from South Africa in the middle of November 2021. SARS-CoV-2 is also called coronavirus disease 2019 (COVID-19) since SARS-CoV-2 is the causative agent of COVID-19. Several studies already suggested that the SARS-CoV-2 Omicron variant would be the fastest transmissible variant compared to the previous 10 SARS-CoV-2 variants of concern, interest, and alert. Few clinical studies reported the high transmissibility of the Omicron variant but there is insufficient time to perform actual experiments to prove it, since the spread is so fast. We analyzed the SARS-CoV-2 Omicron variant, which revealed a very high rate of mutation at amino acid residues that interact with angiostatin-converting enzyme 2. The mutation rate of COVID-19 is faster than what we prepared vaccine program, antibody therapy, lockdown, and quarantine against COVID-19 so far. Thus, it is necessary to find better strategies to overcome the current crisis of COVID-19 pandemic.

Keywords: COVID-19 Omicron; Mutation; Receptor binding motif (RBM); SARS-CoV-2; Spike (S) gene.
 
Back
Top Bottom